Annual D&A
$192.40 K
+$44.00 K+29.65%
31 December 2023
Summary:
Cellectar Biosciences annual depreciation & amortization is currently $192.40 thousand, with the most recent change of +$44.00 thousand (+29.65%) on 31 December 2023. During the last 3 years, it has risen by +$50.90 thousand (+35.97%). CLRB annual D&A is now -87.55% below its all-time high of $1.55 million, reached on 31 December 2017.CLRB Depreciation And Amortization Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly D&A
$68.60 K
+$2600.00+3.94%
30 September 2024
Summary:
Cellectar Biosciences quarterly depreciation & amortization is currently $68.60 thousand, with the most recent change of +$2600.00 (+3.94%) on 30 September 2024. Over the past year, it has increased by +$27.40 thousand (+66.50%). CLRB quarterly D&A is now -94.52% below its all-time high of $1.25 million, reached on 31 December 2017.CLRB Quarterly D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM D&A
$293.10 K
+$27.40 K+10.31%
30 September 2024
Summary:
Cellectar Biosciences TTM depreciation & amortization is currently $293.10 thousand, with the most recent change of +$27.40 thousand (+10.31%) on 30 September 2024. Over the past year, it has increased by +$132.50 thousand (+82.50%). CLRB TTM D&A is now -81.04% below its all-time high of $1.55 million, reached on 31 December 2017.CLRB TTM D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CLRB Depreciation And Amortization Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +29.6% | +66.5% | +82.5% |
| 3 y3 years | +36.0% | +86.4% | +100.1% |
| 5 y5 years | +133.8% | +102.4% | +121.4% |
CLRB Depreciation And Amortization High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | +36.0% | -22.5% | +107.9% | at high | +100.1% |
| 5 y | 5 years | at high | +133.8% | -22.5% | +110.4% | at high | +121.4% |
| alltime | all time | -87.5% | +5912.5% | -94.5% | >+9999.0% | -81.0% | >+9999.0% |
Cellectar Biosciences Depreciation And Amortization History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $68.60 K(+3.9%) | $293.10 K(+10.3%) |
| June 2024 | - | $66.00 K(-25.4%) | $265.70 K(+11.5%) |
| Mar 2024 | - | $88.50 K(+26.4%) | $238.30 K(+23.9%) |
| Dec 2023 | $192.40 K(+29.6%) | $70.00 K(+69.9%) | $192.40 K(+19.8%) |
| Sept 2023 | - | $41.20 K(+6.7%) | $160.60 K(+5.4%) |
| June 2023 | - | $38.60 K(-9.4%) | $152.40 K(+3.2%) |
| Mar 2023 | - | $42.60 K(+11.5%) | $147.70 K(-0.5%) |
| Dec 2022 | $148.40 K(-1.0%) | $38.20 K(+15.8%) | $148.50 K(-0.7%) |
| Sept 2022 | - | $33.00 K(-2.7%) | $149.60 K(-2.5%) |
| June 2022 | - | $33.90 K(-21.9%) | $153.40 K(-3.0%) |
| Mar 2022 | - | $43.40 K(+10.4%) | $158.20 K(+5.5%) |
| Dec 2021 | $149.90 K(+5.9%) | $39.30 K(+6.8%) | $149.90 K(+2.3%) |
| Sept 2021 | - | $36.80 K(-4.9%) | $146.50 K(+0.6%) |
| June 2021 | - | $38.70 K(+10.3%) | $145.60 K(+2.1%) |
| Mar 2021 | - | $35.10 K(-2.2%) | $142.60 K(+0.8%) |
| Dec 2020 | $141.50 K(+6.6%) | $35.90 K(0.0%) | $141.40 K(+2.4%) |
| Sept 2020 | - | $35.90 K(+0.6%) | $138.10 K(+1.5%) |
| June 2020 | - | $35.70 K(+5.3%) | $136.10 K(+1.6%) |
| Mar 2020 | - | $33.90 K(+4.0%) | $134.00 K(+0.9%) |
| Dec 2019 | $132.80 K(+61.4%) | $32.60 K(-3.8%) | $132.80 K(+0.3%) |
| Sept 2019 | - | $33.90 K(+0.9%) | $132.40 K(+15.7%) |
| June 2019 | - | $33.60 K(+2.8%) | $114.40 K(+17.1%) |
| Mar 2019 | - | $32.70 K(+1.6%) | $97.70 K(+18.7%) |
| Dec 2018 | $82.30 K(-94.7%) | $32.20 K(+102.5%) | $82.30 K(-93.7%) |
| Sept 2018 | - | $15.90 K(-5.9%) | $1.30 M(-6.5%) |
| June 2018 | - | $16.90 K(-2.3%) | $1.39 M(-5.7%) |
| Mar 2018 | - | $17.30 K(-98.6%) | $1.48 M(-4.5%) |
| Dec 2017 | $1.55 M(+333.4%) | $1.25 M(+1082.2%) | $1.55 M(+305.3%) |
| Sept 2017 | - | $105.90 K(+4.4%) | $381.50 K(+5.0%) |
| June 2017 | - | $101.40 K(+16.7%) | $363.50 K(+3.0%) |
| Mar 2017 | - | $86.90 K(-0.5%) | $352.80 K(-1.1%) |
| Dec 2016 | $356.70 K(-1.6%) | $87.30 K(-0.7%) | $356.70 K(-1.0%) |
| Sept 2016 | - | $87.90 K(-3.1%) | $360.40 K(-0.8%) |
| June 2016 | - | $90.70 K(-0.1%) | $363.30 K(0.0%) |
| Mar 2016 | - | $90.80 K(-0.2%) | $363.30 K(+0.2%) |
| Dec 2015 | $362.50 K(-1.3%) | $91.00 K(+0.2%) | $362.50 K(+0.4%) |
| Sept 2015 | - | $90.80 K(+0.1%) | $361.00 K(+0.4%) |
| June 2015 | - | $90.70 K(+0.8%) | $359.50 K(-0.4%) |
| Mar 2015 | - | $90.00 K(+0.6%) | $361.10 K(-1.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2014 | $367.20 K(-13.6%) | $89.50 K(+0.2%) | $367.10 K(-2.5%) |
| Sept 2014 | - | $89.30 K(-3.3%) | $376.70 K(-4.2%) |
| June 2014 | - | $92.30 K(-3.9%) | $393.10 K(-3.9%) |
| Mar 2014 | - | $96.00 K(-3.1%) | $408.90 K(-3.7%) |
| Dec 2013 | $424.80 K(-14.6%) | $99.10 K(-6.2%) | $424.80 K(-3.2%) |
| Sept 2013 | - | $105.70 K(-2.2%) | $438.90 K(-2.7%) |
| June 2013 | - | $108.10 K(-3.4%) | $451.20 K(-3.9%) |
| Mar 2013 | - | $111.90 K(-1.1%) | $469.40 K(-5.6%) |
| Dec 2012 | $497.30 K(-15.0%) | $113.20 K(-4.1%) | $497.30 K(-6.1%) |
| Sept 2012 | - | $118.00 K(-6.6%) | $529.40 K(-5.5%) |
| June 2012 | - | $126.30 K(-9.7%) | $560.20 K(-3.5%) |
| Mar 2012 | - | $139.80 K(-3.8%) | $580.50 K(-0.8%) |
| Dec 2011 | $584.80 K(+0.8%) | $145.30 K(-2.4%) | $584.90 K(+0.2%) |
| Sept 2011 | - | $148.80 K(+1.5%) | $583.80 K(+0.8%) |
| June 2011 | - | $146.60 K(+1.7%) | $579.20 K(-16.9%) |
| Mar 2011 | - | $144.20 K(0.0%) | $697.00 K(+20.2%) |
| Dec 2010 | $580.10 K(+1690.4%) | $144.20 K(0.0%) | $580.10 K(+30.1%) |
| Sept 2010 | - | $144.20 K(-45.5%) | $445.80 K(+44.5%) |
| June 2010 | - | $264.40 K(+868.5%) | $308.50 K(+477.7%) |
| Mar 2010 | - | $27.30 K(+175.8%) | $53.40 K(+65.3%) |
| Dec 2009 | $32.40 K(+91.7%) | $9900.00(+43.5%) | $32.30 K(+18.3%) |
| Sept 2009 | - | $6900.00(-25.8%) | $27.30 K(+11.0%) |
| June 2009 | - | $9300.00(+50.0%) | $24.60 K(+25.5%) |
| Mar 2009 | - | $6200.00(+26.5%) | $19.60 K(+16.0%) |
| Dec 2008 | $16.90 K(+9.7%) | $4900.00(+16.7%) | $16.90 K(-2.9%) |
| Sept 2008 | - | $4200.00(-2.3%) | $17.40 K(+3.6%) |
| June 2008 | - | $4300.00(+22.9%) | $16.80 K(+12.0%) |
| Mar 2008 | - | $3500.00(-35.2%) | $15.00 K(-2.6%) |
| Dec 2007 | $15.40 K(+62.1%) | $5400.00(+50.0%) | $15.40 K(+25.2%) |
| Sept 2007 | - | $3600.00(+44.0%) | $12.30 K(+7.9%) |
| June 2007 | - | $2500.00(-35.9%) | $11.40 K(+1.8%) |
| Mar 2007 | - | $3900.00(+69.6%) | $11.20 K(+17.9%) |
| Dec 2006 | $9500.00(+196.9%) | $2300.00(-14.8%) | $9500.00(+4.4%) |
| Sept 2006 | - | $2700.00(+17.4%) | $9100.00(+23.0%) |
| June 2006 | - | $2300.00(+4.5%) | $7400.00(+37.0%) |
| Mar 2006 | - | $2200.00(+15.8%) | $5400.00(+68.8%) |
| Dec 2005 | $3200.00 | $1900.00(+90.0%) | $3200.00(+146.2%) |
| Sept 2005 | - | $1000.00(+233.3%) | $1300.00(+333.3%) |
| June 2005 | - | $300.00 | $300.00 |
FAQ
- What is Cellectar Biosciences annual depreciation & amortization?
- What is the all time high annual D&A for Cellectar Biosciences?
- What is Cellectar Biosciences annual D&A year-on-year change?
- What is Cellectar Biosciences quarterly depreciation & amortization?
- What is the all time high quarterly D&A for Cellectar Biosciences?
- What is Cellectar Biosciences quarterly D&A year-on-year change?
- What is Cellectar Biosciences TTM depreciation & amortization?
- What is the all time high TTM D&A for Cellectar Biosciences?
- What is Cellectar Biosciences TTM D&A year-on-year change?
What is Cellectar Biosciences annual depreciation & amortization?
The current annual D&A of CLRB is $192.40 K
What is the all time high annual D&A for Cellectar Biosciences?
Cellectar Biosciences all-time high annual depreciation & amortization is $1.55 M
What is Cellectar Biosciences annual D&A year-on-year change?
Over the past year, CLRB annual depreciation & amortization has changed by +$44.00 K (+29.65%)
What is Cellectar Biosciences quarterly depreciation & amortization?
The current quarterly D&A of CLRB is $68.60 K
What is the all time high quarterly D&A for Cellectar Biosciences?
Cellectar Biosciences all-time high quarterly depreciation & amortization is $1.25 M
What is Cellectar Biosciences quarterly D&A year-on-year change?
Over the past year, CLRB quarterly depreciation & amortization has changed by +$27.40 K (+66.50%)
What is Cellectar Biosciences TTM depreciation & amortization?
The current TTM D&A of CLRB is $293.10 K
What is the all time high TTM D&A for Cellectar Biosciences?
Cellectar Biosciences all-time high TTM depreciation & amortization is $1.55 M
What is Cellectar Biosciences TTM D&A year-on-year change?
Over the past year, CLRB TTM depreciation & amortization has changed by +$132.50 K (+82.50%)